1. Home
  2. JAZZ vs TXRH Comparison

JAZZ vs TXRH Comparison

Compare JAZZ & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$169.65

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Logo Texas Roadhouse Inc.

TXRH

Texas Roadhouse Inc.

HOLD

Current Price

$166.18

Market Cap

11.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
TXRH
Founded
2003
1993
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
11.0B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
JAZZ
TXRH
Price
$169.65
$166.18
Analyst Decision
Strong Buy
Buy
Analyst Count
15
17
Target Price
$194.40
$189.47
AVG Volume (30 Days)
1.6M
1.0M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
1.64%
EPS Growth
N/A
12.56
EPS
N/A
6.55
Revenue
$4,157,832,999.00
$5,833,958,000.00
Revenue This Year
$6.00
$11.90
Revenue Next Year
$6.84
$10.41
P/E Ratio
N/A
$25.38
Revenue Growth
4.14
14.40
52 Week Low
$95.49
$148.73
52 Week High
$182.99
$199.99

Technical Indicators

Market Signals
Indicator
JAZZ
TXRH
Relative Strength Index (RSI) 62.19 44.55
Support Level $164.44 $165.70
Resistance Level $182.75 $178.68
Average True Range (ATR) 5.88 3.80
MACD -1.21 -0.42
Stochastic Oscillator 34.58 3.70

Price Performance

Historical Comparison
JAZZ
TXRH

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

Share on Social Networks: